Kristoffer Stewart (@PharmKristoffer) header
Kristoffer Stewart (@PharmKristoffer) profile picture

Clinical editor @BMJOncology & BMJ Immunology https://xitter.cf/t.co/1r8GtdJUWW Pharmacist turned editor he/his #ClinicalEditor #Oncology

London, England
Joined August 2015
Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)Photo by Kristoffer Stewart (@PharmKristoffer)
Kristoffer Stewart retweeted
AI pathology may speed patient selection and make cancer-trial assessments more consistent. This review explains what it takes to reach patients: reliable tissue data, connected lab systems and validation across hospitals. bmjoncology.bmj.com/content/…
1
4
9
306
Excited to be at #ESMO26 Hoping to get some great ideas for @BMJOncology and discuss the latest in cancer care that moves from science to patient care. The place is huge but if you want to chat dm me
1
2
1
101
No surprise to anyone AI is top of the agenda
1
39
Kristoffer Stewart retweeted
A (candid) photo of the BMJ Oncology editorial board! We met this week to discuss the journal's growth and advancement. We strive to be a global journal covering the full breadth of oncology. @MassimoDiMaio75 @kjmeetswrld @achoud72 @DrTakemura @YatTsang @elivaos @BreastDocUK
5
1
8
837
Kristoffer Stewart retweeted
More decentralisation ≠ better trials. In our new @BMJOncology editorial, responding to new UK data on decentralised oncology trials, we argue that the target should not be “how decentralised can we make this?” It should be: does this design actually make trial participation easier and more patient-centred? DCT is the tool. Patient-centred access is the goal. Really proud of Jordan Cohen for leading this work as part of his PhD, with @angelacwebster and @Njt14 🔗: bmjoncology.bmj.com/content/… 🔗 main paper: dx.doi.org/10.1136/bmjonc-20… #ClinicalTrials #DecentralisedTrials #PatientCentredCare #CancerResearch
5
12
685
Kristoffer Stewart retweeted
This new systematic review found a lack of evidence providing direct comparisons between endourological treatment versus segmental ureterectomy for upper tract urothelial carcinoma. bmjoncology.bmj.com/content/…
1
2
172
Kristoffer Stewart retweeted
Air pollution is a global health issue with significant effect on many non-communicable diseases including asthma, birth defects, cancer, cardiovascular and cerebrovascular disease, diabetes, neurodevelopmental disorders and respiratory diseases bmjoncology.bmj.com/content/…
3
2
171
Kristoffer Stewart retweeted
In this review, McCarthy and Snape give an overview of constitutional genetic susceptibility to cancer, how to assess and identify enhanced susceptibility and exemplars of how this influences precision management. 🔗 bmjoncology.bmj.com/content/… @OncoAlert #OncoAlert
1
2
6
610
Kristoffer Stewart retweeted
What is radiotheranostics? How does it allow for precise tumour visualisation and treatment? Read this recent review to find out! bmjoncology.bmj.com/content/…
1
1
4
571
Kristoffer Stewart retweeted
A new study in our journal was covered by Good Morning America 40% of women with ovarian cancer are only diagnosed after an emergency room admission This emergency route leaves patients three times less likely to catch the disease at an early stage bmjoncology.bmj.com/content/…
3
4
352
Kristoffer Stewart retweeted
The concept of oligometastatic disease has reshaped the management paradigm for many solid tumours because some patients may achieve long-term disease control or even cure with aggressive local therapy. bmjoncology.bmj.com/content/…
8
14
1,520
Kristoffer Stewart retweeted
New article out looking at what can be done to bridge the gap between what's possible in the lab and what's available in the clinic.
2
1
230
Another part-time role at the BMJ has become available: Clinical Editor at BMJ Endocrinology. I want to encourage anyone who has experience as an editor and/or as a as a healthcare professional working in the area of endocrinology to apply! jobsearch.bmj.com/jobs/job/C…
1
349
Kristoffer Stewart retweeted
The TIGIT catastrophe‼️ 30 agents 220 trials ~50,000 patients >$3B+ invested 0 approvals. This is herding in drug development. In BMJ Oncol we examine why it happens, the hidden costs, and what needs to change. It’s already happening again in ADCs... 🔗:bmjoncology.bmj.com/content/…
8
87
14
305
77,972
Kristoffer Stewart retweeted
Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detection Great review👇 bmjoncology.bmj.com/content/…
17
2
56
3,907
Another part-time role at the BMJ has become available: Clinical Editor at BMJ Infectious Diseases. jobsearch.bmj.com/jobs/job/C… I encourage anyone who has experience as an editor and/or as a as a healthcare professional working in the area of infectious disease to consider applying
1
1
1
291
This is a new journal, meaning you'll have plenty of opportunities to develop as an editor and shape research at the BMJ. If anyone is interested let me know, I'm happy to share my experience as a clinical editor.
71